Skip to main content

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in neurological and CNS disorders. As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders) was previously published as Current Drug Targets-CNS & Neurological Disorders.

Publisher: Bentham Science Publishers

Volume 8, Number 1, March 2009


Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimer's Disease
pp. 16-30(15)
Authors: Deane, R.; Bell, R. D.; Sagare, A.; Zlokovic, B. V.


Quantitative and Mechanistic Studies of Aβ Immunotherapy
pp. 31-49(19)
Authors: Golde, Todd E.; Das, Pritam; Levites, Yona


Immunotherapy, Vascular Pathology, and Microhemorrhages in Transgenic Mice
pp. 50-64(15)
Authors: Wilcock, Donna M.; Colton, Carol A.


Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid β-Derived Neurotoxins
pp. 65-81(17)
Authors: Lambert, Mary P.; Velasco, Pauline T.; Viola, Kirsten L.; Klein, William L.


Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more